Russell Investments Group
ANIK icon

Russell Investments Group’s Anika Therapeutics ANIK Stock Holding History

Russell Investments Group’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47K Buy
3,243
+1,522
+88% +$17.7K ﹤0.01% 3352
2025
Q4 		$16.5K Sell
1,721
-279
-14% -$2.67K ﹤0.01% 3678
2025
Q3 		$18.8K Buy
2,000
+1,469
+277% +$14K ﹤0.01% 3605
2025
Q2 		$5.62K Buy
531
+95
+22% +$1.2K ﹤0.01% 3426
2025
Q1 		$6.55K Buy
436
+165
+61% +$2.75K ﹤0.01% 3302
2024
Q4 		$4.46K Buy
271
+102
+60% +$2.01K ﹤0.01% 3309
2024
Q3 		$4.17K Buy
169
+98
+138% +$2.54K ﹤0.01% 3259
2024
Q2 		$1.8K Buy
71
+25
+54% +$648 ﹤0.01% 3367
2024
Q1 		$1.17K Buy
46
+12
+35% +$290 ﹤0.01% 3122
2023
Q4 		$770 Buy
+34
New +$704 ﹤0.01% 3087
2023
Q3 		– Sell
-602
Closed -$15.6K – 3520
2023
Q2 		$15.6K Sell
602
-54
-8% -$1.45K ﹤0.01% 2885
2023
Q1 		$18.8K Sell
656
-86,222
-99% -$2.57M ﹤0.01% 2821
2022
Q4 		$2.57M Sell
86,878
-10,463
-11% -$298K 0.01% 1430
2022
Q3 		$2.32M Sell
97,341
-7,500
-7% -$173K 0.01% 1465
2022
Q2 		$2.34M Buy
104,841
+3,200
+3% +$71.4K ﹤0.01% 1507
2022
Q1 		$2.55M Sell
101,641
-5,823
-5% -$178K ﹤0.01% 1511
2021
Q4 		$3.85M Sell
107,464
-10,932
-9% -$438K 0.01% 1416
2021
Q3 		$5.04M Sell
118,396
-22,445
-16% -$924K 0.01% 1248
2021
Q2 		$6.09M Sell
140,841
-112,348
-44% -$4.79M 0.01% 1219
2021
Q1 		$10.3M Buy
253,189
+46,728
+23% +$1.77M 0.02% 921
2020
Q4 		$9.34M Buy
206,461
+66,236
+47% +$2.51M 0.02% 897
2020
Q3 		$4.96M Buy
140,225
+31,627
+29% +$1.14M 0.01% 1131
2020
Q2 		$3.98M Buy
108,598
+49,844
+85% +$1.64M 0.01% 1234
2020
Q1 		$1.68M Buy
58,754
+6,469
+12% +$262K ﹤0.01% 1558
2019
Q4 		$2.72M Buy
52,285
+17,042
+48% +$990K 0.01% 1567
2019
Q3 		$1.93M Buy
35,243
+9,239
+36% +$474K ﹤0.01% 1698
2019
Q2 		$1.05M Sell
26,004
-8,892
-25% -$324K ﹤0.01% 1965
2019
Q1 		$1.05M Buy
34,896
+6,169
+21% +$211K ﹤0.01% 2038
2018
Q4 		$966K Sell
28,727
-26,743
-48% -$965K ﹤0.01% 1984
2018
Q3 		$2.34M Buy
55,470
+15,853
+40% +$626K ﹤0.01% 1679
2018
Q2 		$1.27M Sell
39,617
-5,941
-13% -$245K ﹤0.01% 1993
2018
Q1 		$2.27M Sell
45,558
-7,847
-15% -$443K ﹤0.01% 1766
2017
Q4 		$2.85M Buy
53,405
+9,545
+22% +$528K ﹤0.01% 1649
2017
Q3 		$2.54M Sell
43,860
-6,647
-13% -$347K ﹤0.01% 1647
2017
Q2 		$2.49M Sell
50,507
-12,100
-19% -$557K ﹤0.01% 1607
2017
Q1 		$2.72M Sell
62,607
-49,873
-44% -$2.38M 0.01% 1581
2016
Q4 		$5.53M Buy
+112,480
New +$5.2M 0.01% 1178

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Russell Investments Group's ANIK Position: Q1 2026 in Review

Russell Investments Group increased its Anika Therapeutics (ANIK) stake by 88% in Q1 2026, buying an estimated $17.7K and bringing the position to 3,243 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #3352.

Russell Investments Group first reported a position in ANIK in Q4 2016 and has held it in 37 quarters since. The position peaked at $10.3M in Q1 2021. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Russell Investments Group held 3,243 shares of Anika Therapeutics worth $47K as of Q1 2026.
  • Russell Investments Group bought 1,522 Anika Therapeutics shares in Q1 2026, an estimated $17.7K.
  • Anika Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3352 holding.
  • Russell Investments Group first reported a position in Anika Therapeutics in Q4 2016 and has held it in 37 quarters since.
  • Russell Investments Group's Anika Therapeutics position peaked at $10.3M in Q1 2021.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.